Atropine sulfate auto-injector, training device, training - TO1
Ended Awarded Last action
- Contract number
- HHSD2002017925240001
- Awardee
-
Rafa Laboratories LTD UEI CKDNTKNDPMJ6
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $7,047,000
Award facts
- Opportunity
-
- 2017N18111 Solicitation number
- Contract value 100% obligated
- $7,047,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Israel
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$10,000 | |
| Original award | $7,057,000 |
About this award
This is a firm fixed-price delivery order awarded by the Centers for Disease Control and Prevention (CDC) to Rafa Laboratories LTD, a foreign-owned, for-profit manufacturer, for the supply of atropine sulfate auto-injectors, training devices, and related training services. The contract has a total ceiling value of $7,047,000.00 and a period of performance ending on September 15, 2017. No set-aside designation was used for this award.
Rafa Laboratories LTD has previously held prime contracts with the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) and the Department of the Army's Joint Program Executive Office for Chemical and Biological Defense, providing medical countermeasures such as autoinjectors and related training products and services. The company currently holds an Indefinite Delivery Vehicle (IDV) contract with the Department of the Army's Joint Program Executive Office for Chemical and Biological Defense, valued at up to $48,200,000, to provide Food and Drug Administration-approved midazolam autoinjectors for chemical and biological defense programs.
Quick answers
Who was awarded contract HHSD2002017925240001?
HHSD2002017925240001 was awarded to Rafa Laboratories LTD by CDC Pittsburgh (Centers for Disease Control and Prevention) on January 31, 2017.
How much is contract HHSD2002017925240001 worth?
The government has obligated $7,047,000 on HHSD2002017925240001.
Is contract HHSD2002017925240001 an order under another contract?
Yes. HHSD2002017925240001 is a delivery order under HHSD200201792524I, an indefinite delivery contract.
Was contract HHSD2002017925240001 competed?
The extent of competition for HHSD2002017925240001 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award